quickly get a reliabe diagnosis

Innovation for laboratories



reliable diagnosis

Questions regarding GynTect?

Get the answers!

Welcome at oncgnostics GmbH Jena

Reliable cancer diagnosis

Development of molecular assays based on epigenetic biomarkers which allow early and reliable cancer diagnostics – this is the intention of oncgnostics!

Improve diagnosis

Our products should allow an early detection of diseases to substantially inprove therapy success. Notice: if detected early, almost all cancer cases are curable.


If you would like us to keep you informed about news related to our company, please sign in for our quarterly newsletter.


Neuer Standort der oncgnostics GmbH in Jena Nordoncgnostics GmbH

We’ve moved: More space for new challenges

At the beginning of May, things were turbulent, because we moved into our new offices and laboratories. The new location in a business park in Jena enables us to create more opportunities for our company growth and to increase our (international)…

Study „OroCa-Graz“ – Study on Head-and-Neck tumors: oncgnostics GmbH cooperates with the Medical University of Graz

The biotechnology company oncgnostics GmbH is researching a method for diagnosing Head-and-Neck tumors together with the clinical department for general ENT at the Medical University of Graz as part of the “OroCa-Graz” study. 550,000 people…
Vertriebspartnerschaft zwischen der oncgnostics GmbH und der EUROIMMUN Medizinische Labordiagnostika AGoncgnostics GmbH Susann Nuernberger / EUROIMMUN Medizinische Labordiagnostika AG

International sales partnership with EUROIMMUN for Distribution of GynTect

Biotechnology company oncgnostics GmbH is announcing a collaboration with the international diagnostics group EUROIMMUN, a PerkinElmer company. As part of the cooperation, EUROIMMUN will sell the cervical cancer test from oncgnostics GmbH, Gyn-Tect,…

oncgnostics GynTect

Our fist product, GynTect®, enables reliable and fast diagnosis of cervical cancer and pre-cancerous stages.

Video in German.